Companies Cryptocurrencies
Assertio Holdings Inc
Assertio Holdings Inc
Exchange: NasdaqGS
IPO Date: 12/02/1997
CEO: Mr. Arthur Higgins
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • ASRT
  • 1.02
  • 45383980
    market cap
  • 0.04479998
If you bought

shares of Assertio Holdings Inc (ASRT) on
You would have made
Old Price $12 Current Price $12

Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Suspension, INDOCIN (indomethacin) Suppositories, OXAYDO tablets, SPRIX Nasal Spray, VIVLODEX capsules, ZIPSOR Liquid filled capsules and ZORVOLEX capsules. The Company is also focused on developing and commercializing neurology, orphan and specialty medicines. Its pipeline products include Diclofenac Potassium, Long-acting Cosyntropin and Diclofenac potassium. Diclofenac Potassium is being developed for mild/moderate acute pain. Long-acting Cosyntropin is being developed for diagnosis of adrenal insufficiency. Diclofenac potassium is a liquid formulation being developed for acute migraine attacks.

Address: 100 S. Saunders Road Suite 300 Lake Forest ILLINOIS 60045

Stay updated.